Skip to main content
. 2017 May 29;6(7):1707–1719. doi: 10.1002/cam4.1096

Figure 4.

Figure 4

Validation of the three‐gene signature. Kaplan–Meier estimates of overall survival of ESCC patients according to the three‐gene signature in the testing cohort (A) and the validation cohort (B). (C) Representative low/high expression of LOXL2,CDH1, and FN1 by immunochemistry study in tissue microarrays. The bar indicates 50 μm. (D) Kaplan–Meier curves of the three‐gene signature for overall survival in the validation tissue microarray cohort.